Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Fall 2011 - Innovation
Download Issue
Share
Up Front
Publisher's Corner
Back to the Future
By Patrick M. Schmidt
Features
A World Without Vaccines
By
Trudie Mitschang
Nuclear Accidents: Determining Fukushima’s Health Consequences
By
Robert Peter Gale, MD, PhD
Myths and Facts: Fibromyalgia
By
Ronale Tucker Rhodes, MS
The Future of Molecular Imaging
By
John Otrompke, JD
The Role of Less-Common Hyperimmune Globulins
By
E. Richard Stiehm, MD
What’s New in Anti-Diabetic and Cardiovascular Drugs
By
Jennifer Kester
BioTrends Watch
Washington Report
Legislation Protects the Treatment of Rare Diseases
EEOC Issues Final Regulations Interpreting the ADA Amendments Act
Healthcare Reform Rule Bans Unreasonable Premium Increases
Part D Drug Premiums to Decrease in 2012
Reimbursement FAQs
Reimbursement FAQs
Industry News
Study Tests an Adjuvant to Vaccinate Newborns
HPV Vaccine Reduces Cervical Abnormalities
Vaccine Prevents Heroin High in Animals
Test Can Predict Immune Responses to Flu Shots
People and Places in the News
FDA Approves Rituxan for Two Rare Disorders
Baxter Receives FDA Approval for Gammagard Liquid
Lower Cholesterol May Fight Infections
Kedrion Launches FDA-Approved Gammaked in the U.S. Market
Grant Makes Needle-Free Vaccine a Reality
New Alzheimer's Diagnostic Criteria Are Finalized
Study to Assess Safety of Meningitis Vaccine During Pregnancy
FDA Approves Menactra for Infants from 9 Months
BioFocus
Industry Insight
Under the Skin Is in
By Keith Berman, MPH, MBA
Patient Profile
Regaining Quality of Life
By Trudie Mitschang
BioSources
BioResearch
IVIG May Confer Relief in Specific Types of Neuropathy Associated with Sjögren’s Syndrome
Secondary Prophylaxis with Factor VIII/VWF Concentrate Sharply Reduces Bleeding in Patients with von Willebrand Disease
Two Full Doses of Influenza Vaccine Improves Immunogenicity Versus Two Half-Doses in Infants